A lot of what you need to know about Neogen (NEOG) can be summed up thusly - after a nearly 25% pullback from the 52-week on tariff-related headwinds, the shares still aren't even close to undervalued by any conventional valuation approach. As I've said in the past, Neogen shares live in their own world where valuation is concerned, as institutions (over 90% of the ownership base is institutional) seem to be valuation-insensitive when it comes to owning a pure-play on food safety and food/production animal care.
I don't think the headwinds that Neogen is seeing